Mengyan Li
Xinjiang Medical University(CN)First Affiliated Hospital of Xinjiang Medical University(CN)
Publications by Year
Research Areas
Immune Cell Function and Interaction, CAR-T cell therapy research, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, T-cell and B-cell Immunology
Most-Cited Works
- → Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model(2019)155 cited
- → T cell receptor–targeted immunotherapeutics drive selective in vivo HIV- and CMV-specific T cell expansion in humanized mice(2021)24 cited
- → Suppressor gene GRHL1 is associated with prognosis in patients with oesophageal squamous cell carcinoma(2019)8 cited
- → Intelligent Biomatrices and Engineered Tissue Constructs: In‐Vitro Models for Drug Discovery and Toxicity Testing(2006)8 cited
- → Application of Novel T Cell Immunotherapeutics to Drive Antigen-Specific Activation, Expansion, and Differentiation of CD19 Chimeric Antigen Receptor T Cells (CAR T-cells)(2020)2 cited
- → The effect of SOX17, MACC1 and c-Met expression in ESCC on prognosis(2021)1 cited
- → Analysis and Application of Antagonism Compound Prescription Compatibility(2018)1 cited
- → 623 Immuno-STATs: Leveraging protein engineering to expand and track antigen-specific T cells in vivo(2020)1 cited
- → Pancancer analysis of DCTPP1 and the impact of the combined knockdown of DCTPP1 with docetaxel on breast cancer(2025)
- → Prognostic Value of UBE2S, HIF‐1α, and FOXM1 Expression in Esophageal Squamous Cell Carcinoma(2025)